Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESOMEPRAZOLE Cause Weight increased? 415 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 415 reports of Weight increased have been filed in association with ESOMEPRAZOLE (Esomeprazole Magnesium). This represents 0.6% of all adverse event reports for ESOMEPRAZOLE.

415
Reports of Weight increased with ESOMEPRAZOLE
0.6%
of all ESOMEPRAZOLE reports
9
Deaths
169
Hospitalizations

How Dangerous Is Weight increased From ESOMEPRAZOLE?

Of the 415 reports, 9 (2.2%) resulted in death, 169 (40.7%) required hospitalization, and 15 (3.6%) were considered life-threatening.

Is Weight increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE. However, 415 reports have been filed with the FAERS database.

What Other Side Effects Does ESOMEPRAZOLE Cause?

Chronic kidney disease (35,281) Acute kidney injury (18,678) Renal failure (14,633) End stage renal disease (10,231) Renal injury (9,440) Gastrooesophageal reflux disease (4,746) Drug ineffective (4,420) Tubulointerstitial nephritis (4,024) Off label use (3,180) Pain (2,898)

What Other Drugs Cause Weight increased?

ADALIMUMAB (7,724) INFLIXIMAB (7,639) PREDNISONE (7,348) RISPERIDONE (6,885) METHOTREXATE (6,616) TOCILIZUMAB (6,425) RITUXIMAB (6,148) TOFACITINIB (5,342) ETANERCEPT (5,327) PREGABALIN (4,903)

Which ESOMEPRAZOLE Alternatives Have Lower Weight increased Risk?

ESOMEPRAZOLE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE ESOMEPRAZOLE vs ESOMEPRAZOLE\NAPROXEN ESOMEPRAZOLE vs ESTAZOLAM ESOMEPRAZOLE vs ESTRADIOL ESOMEPRAZOLE vs ESTRADIOL CYPIONATE

Related Pages

ESOMEPRAZOLE Full Profile All Weight increased Reports All Drugs Causing Weight increased ESOMEPRAZOLE Demographics